why is the fda banning compounded semaglutide "semaglutide" not FDA-approved US judge upholds FDA's removal

GLP-1 medications provide support by helping the body respond more predictably to food and improving satiety cues that often become weaker with age

Evaluations of cognitive functions objectivize deficits in inhibition, cognitive flexibility and working memory

Here is how visibility impacts drug spend: Aggregate reporting gives employers a total, not a picture of what's actually driving it Without claim-level detail, rebate pass-through is impossible to verify independently Biosimilar substitution opportunities are invisible without drug-level utilization data Meaningful oversight starts with the right data structure, not just more volume Fragmentation between pharmacy and medical benefits

While she has lost some weight since starting Zepbound in 2024, she says it's not as dramatic as other people have experienced